Literature DB >> 29950412

The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.

Vu Thuy Khanh Le-Trilling1, Ofer Mandelboim2, Liat Dassa3, Einat Seidel3, Esther Oiknine-Djian4,5,6, Rachel Yamin3, Dana G Wolf4,5,6.   

Abstract

Natural killer (NK) cells are lymphocytes of the innate immune system capable of killing hazardous cells, including virally infected cells. NK cell-mediated killing is triggered by activating receptors. Prominent among these is the activating receptor NKG2D, which binds several stress-induced ligands, among them major histocompatibility complex (MHC) class I-related chain A (MICA). Most of the human population is persistently infected with human cytomegalovirus (HCMV), a virus which employs multiple immune evasion mechanisms, many of which target NK cell responses. HCMV infection is mostly asymptomatic, but in congenitally infected neonates and in immunosuppressed patients it can lead to serious complications and mortality. Here we discovered that an HCMV protein named UL148A whose role was hitherto unknown is required for evasion of NK cells. We demonstrate that UL148A-deficient HCMV strains are impaired in their ability to downregulate MICA expression. We further show that when expressed by itself, UL148A is not sufficient for MICA targeting, but rather acts in concert with an unknown viral factor. Using inhibitors of different cellular degradation pathways, we show that UL148A targets MICA for lysosomal degradation. Finally, we show that UL148A-mediated MICA downregulation hampers NK cell-mediated killing of HCMV-infected cells. Discovering the full repertoire of HCMV immune evasion mechanisms will lead to a better understanding of the ability of HCMV to persist in the host and may also promote the development of new vaccines and drugs against HCMV.IMPORTANCE Human cytomegalovirus (HCMV) is a ubiquitous pathogen which is usually asymptomatic but that can cause serious complications and mortality in congenital infections and in immunosuppressed patients. One of the difficulties in developing novel vaccines and treatments for HCMV is its remarkable ability to evade our immune system. In particular, HCMV directs significant efforts to thwarting cells of the innate immune system known as natural killer (NK) cells. These cells are crucial for successful control of HCMV infection, and yet our understanding of the mechanisms which HCMV utilizes to elude NK cells is partial at best. In the present study, we discovered that a protein encoded by HCMV which had no known function is important for preventing NK cells from killing HCMV-infected cells. This knowledge can be used in the future for designing more-efficient HCMV vaccines and for formulating novel therapies targeting this virus.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HCMV; NK cells; immune evasion

Mesh:

Substances:

Year:  2018        PMID: 29950412      PMCID: PMC6096798          DOI: 10.1128/JVI.00162-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

Review 2.  Advances in NKG2D ligand recognition and responses by NK cells.

Authors:  Nina Le Bert; Stephan Gasser
Journal:  Immunol Cell Biol       Date:  2014-01-21       Impact factor: 5.126

3.  The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling.

Authors:  Vu Thuy Khanh Le; Mirko Trilling; Hartmut Hengel
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

4.  Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs.

Authors:  Ramazan Atalay; Albert Zimmermann; Markus Wagner; Eva Borst; Christine Benz; Martin Messerle; Hartmut Hengel
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141.

Authors:  Peter Tomasec; Eddie C Y Wang; Andrew J Davison; Borivoj Vojtesek; Melanie Armstrong; Cora Griffin; Brian P McSharry; Rebecca J Morris; Sian Llewellyn-Lacey; Carole Rickards; Akio Nomoto; Christian Sinzger; Gavin W G Wilkinson
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

6.  New advances in CMV and immunosenescence.

Authors:  Paolo Sansoni; Rosanna Vescovini; Francesco F Fagnoni; Arne Akbar; Ramon Arens; Yen-Ling Chiu; Luka Cičin-Šain; Julie Dechanet-Merville; Evelyna Derhovanessian; Sara Ferrando-Martinez; Claudio Franceschi; Daniela Frasca; Tamas Fulöp; David Furman; Effrossyni Gkrania-Klotsas; Felicia Goodrum; Beatrix Grubeck-Loebenstein; Mikko Hurme; Florian Kern; Daniele Lilleri; Miguel López-Botet; Andrea B Maier; Thomas Marandu; Arnaud Marchant; Catharina Matheï; Paul Moss; Aura Muntasell; Ester B M Remmerswaal; Natalie E Riddell; Kathrin Rothe; Delphine Sauce; Eui-Cheol Shin; Amanda M Simanek; Megan J Smithey; Cecilia Söderberg-Nauclér; Rafael Solana; Paul G Thomas; Rene van Lier; Graham Pawelec; Janko Nikolich-Zugich
Journal:  Exp Gerontol       Date:  2014-04-03       Impact factor: 4.032

7.  Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.

Authors:  O Mandelboim; H T Reyburn; M Valés-Gómez; L Pazmany; M Colonna; G Borsellino; J L Strominger
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

Review 8.  Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?

Authors:  Anne Halenius; Carolin Gerke; Hartmut Hengel
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

Review 9.  Natural killer cells as an initial defense against pathogens.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2006-06-12       Impact factor: 7.486

10.  Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA∗008 to Escape Elimination by NK Cells.

Authors:  Einat Seidel; Vu Thuy Khanh Le; Yotam Bar-On; Pinchas Tsukerman; Jonatan Enk; Rachel Yamin; Natan Stein; Dominik Schmiedel; Esther Oiknine Djian; Yiska Weisblum; Boaz Tirosh; Peter Stastny; Dana G Wolf; Hartmut Hengel; Ofer Mandelboim
Journal:  Cell Rep       Date:  2015-02-12       Impact factor: 9.423

View more
  13 in total

Review 1.  Immune evasion by adenoviruses: a window into host-virus adaptation.

Authors:  Edson R A Oliveira; Marlene Bouvier
Journal:  FEBS Lett       Date:  2019-12-05       Impact factor: 4.124

Review 2.  Virus-host protein interactions as footprints of human cytomegalovirus replication.

Authors:  Matthew D Tyl; Cora N Betsinger; Ileana M Cristea
Journal:  Curr Opin Virol       Date:  2021-12-16       Impact factor: 7.090

3.  The Roseoloviruses Downregulate the Protein Tyrosine Phosphatase PTPRC (CD45).

Authors:  Melissa L Whyte; Kelsey A Smith; Amanda Buchberger; Linda Berg Luecke; Lidya Handayani Tjan; Yasuko Mori; Rebekah L Gundry; Amy W Hudson
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

4.  TRANSPIRE: A Computational Pipeline to Elucidate Intracellular Protein Movements from Spatial Proteomics Data Sets.

Authors:  Michelle A Kennedy; William A Hofstadter; Ileana M Cristea
Journal:  J Am Soc Mass Spectrom       Date:  2020-05-29       Impact factor: 3.262

Review 5.  Molecular mechanisms of human herpes viruses inferring with host immune surveillance.

Authors:  Simon Jasinski-Bergner; Ofer Mandelboim; Barbara Seliger
Journal:  J Immunother Cancer       Date:  2020-07       Impact factor: 13.751

Review 6.  HCMV-Encoded NK Modulators: Lessons From in vitro and in vivo Genetic Variation.

Authors:  Mihil Patel; Virginia-Maria Vlahava; Simone K Forbes; Ceri A Fielding; Richard J Stanton; Eddie C Y Wang
Journal:  Front Immunol       Date:  2018-10-01       Impact factor: 8.786

Review 7.  Subversion of Immune Response by Human Cytomegalovirus.

Authors:  A Raj Kumar Patro
Journal:  Front Immunol       Date:  2019-06-10       Impact factor: 7.561

Review 8.  NK Cell Memory to Cytomegalovirus: Implications for Vaccine Development.

Authors:  Calum Forrest; Ariane Gomes; Matthew Reeves; Victoria Male
Journal:  Vaccines (Basel)       Date:  2020-07-20

9.  A slowly cleaved viral signal peptide acts as a protein-integral immune evasion domain.

Authors:  Einat Seidel; Liat Dassa; Shira Kahlon; Boaz Tirosh; Anne Halenius; Tal Seidel Malkinson; Ofer Mandelboim
Journal:  Nat Commun       Date:  2021-04-06       Impact factor: 14.919

Review 10.  Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches.

Authors:  Stefania Mantovani; Barbara Oliviero; Stefania Varchetta; Dalila Mele; Mario U Mondelli
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.